J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion

J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion

Source: 
Fierce Pharma
snippet: 

Legend Biotech, Johnson & Johnson’s partner on closely watched CAR-T therapy Carvykti, is looking for additional funding as the drug launches and the Chinese biotech's global expansion kicks into gear.